US Drug Recall Register
Class II · Moderate risk Terminated Initiated Aug 27, 2014 (12 years ago)

Cyclosporine 200 mg/mL opthalmic suspension packaged in an amber…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

What was recalled

Cyclosporine 200 mg/mL opthalmic suspension packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.

Recalling firm
Martin Avenue Pharmacy, Inc.
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0073-2015

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Cyclosporine recalls

See all
Class III · Low risk Ongoing

Klarity-C Drops

Reason Subpotent Drug

Imprimis NJOF, LLC NDC 71384-514-05 D-0157-2026
Class II · Moderate risk Ongoing

Klarity-C

Reason Lack of Assurance of Sterility

Imprimis NJOF, LLC D-0547-2024
Class I · High risk Ongoing

SANDIMMUNE Oral Solution

Reason Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals

Novartis Pharmaceuticals Corporation NDC 0078-0110-22 D-0144-2024
Class I · High risk Ongoing

SANDIMMUNE Oral Solution

Reason Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals.

Novartis Pharmaceuticals Corp. NDC 0078-0110-22 D-1174-2023
Class III · Low risk Terminated

Cequa

Reason Subpotent: Out of Specification result observed for low assay

Sun Pharmaceutical Industries INC NDC 47335-506-96 D-1172-2023